Skip to content
ppharmaranks
Menu

Best Calcitonin Gene-related Peptide Receptor Antagonist for migraine without aura

Top-rated pick: Ubrelvy — pharmaranks score 72/100, the highest of the 2 Calcitonin Gene-related Peptide Receptor Antagonist drugs used for migraine without aura, ranked by our independent FDA recall-safety score. Compare them with all treatments for migraine without aura or the full Calcitonin Gene-related Peptide Receptor Antagonist class. Not medical advice — always consult a professional.

Quick answer: Of the 2 calcitonin gene-related peptide receptor antagonist drugs we rate for migraine without aura, none are yet flagged as generics in our price data, and most are tablet. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for migraine without aura; the right choice depends on your situation, so confirm it with your prescriber.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Get treated for migraine without aura online

Licensed online providers — consult & get prescribed if eligible.

Advertising disclosure: We may earn a commission, at no extra cost to you. This never affects our ratings. Details

Top calcitonin gene-related peptide receptor antagonist for migraine without aura: 1. Ubrelvy · 2. Zavzpret

Best-rated Calcitonin Gene-related Peptide Receptor Antagonist for migraine without aura, ranked by pharmaranks score
#DrugRatingPharmacy pays
172/100View →
264/100View →

Full ranking · 2 drugs

Frequently asked

What is the best calcitonin gene-related peptide receptor antagonist for migraine without aura?
By our independent recall-safety rating — not an efficacy measure — ubrelvy ranks highest among Calcitonin Gene-related Peptide Receptor Antagonist drugs used for migraine without aura. Always consult a professional.
Which calcitonin gene-related peptide receptor antagonist drugs treat migraine without aura?
pharmaranks lists 2 Calcitonin Gene-related Peptide Receptor Antagonist products used for migraine without aura, per NIH RxClass drug-classification data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.